Haemolaser Therapy for the Treatment of Long COVID Symptoms

A clinical study was conducted between January and May 2021 to evaluate the potential benefits of haemolaser therapy for patients experiencing Long COVID symptoms.

A total of 32 patients, treated either as inpatients or outpatients, participated in the study and were assessed for changes in their symptoms following treatment.

The results indicated improvements in several commonly reported Long COVID symptoms, including:

• Reduction in pain
• Improvement in fatigue symptoms
• Reduction in coughing
• Improvement in shortness of breath
• Better sleep quality

The full study text is provided below.